The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year Experience.
Magdolna DankDorottya MühlAnnamária PölhösRenata CsandaMagdolna HeroldAttila Kristof KovacsLilla MadarasJanina KulkaTimea PalhazyAnna-Maria TokesMonika TothMihaly UjhelyiAttila Marcell SzaszZoltan HeroldPublished in: Genes (2023)
Our study supports the existing understanding of molecular subtypes in breast cancer and emphasizes the overlap between clinical characteristics and molecular subtyping. These findings underscore the value of gene expression profiling, such as PAM50, in improving treatment decisions for breast cancer patients.